164 related articles for article (PubMed ID: 26704864)
1. Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight.
Holzberg JR; Jin R; Le NA; Ziegler TR; Brunt EM; McClain CJ; Konomi JV; Arteel GE; Vos MB
J Pediatr Gastroenterol Nutr; 2016 Jun; 62(6):819-23. PubMed ID: 26704864
[TBL] [Abstract][Full Text] [Related]
2. 1H-MRS Measured Ectopic Fat in Liver and Muscle in Danish Lean and Obese Children and Adolescents.
Fonvig CE; Chabanova E; Andersson EA; Ohrt JD; Pedersen O; Hansen T; Thomsen HS; Holm JC
PLoS One; 2015; 10(8):e0135018. PubMed ID: 26252778
[TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
4. Metabolic consequences of hepatic steatosis in overweight and obese adolescents.
Wicklow BA; Wittmeier KD; MacIntosh AC; Sellers EA; Ryner L; Serrai H; Dean HJ; McGavock JM
Diabetes Care; 2012 Apr; 35(4):905-10. PubMed ID: 22357180
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.
Targher G; Bertolini L; Scala L; Zoppini G; Zenari L; Falezza G
Diabet Med; 2005 Oct; 22(10):1354-8. PubMed ID: 16176196
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.
Ferraioli G; Calcaterra V; Lissandrin R; Guazzotti M; Maiocchi L; Tinelli C; De Silvestri A; Regalbuto C; Pelizzo G; Larizza D; Filice C
BMC Gastroenterol; 2017 May; 17(1):61. PubMed ID: 28472948
[TBL] [Abstract][Full Text] [Related]
8. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Verrijken A; Francque S; Mertens I; Prawitt J; Caron S; Hubens G; Van Marck E; Staels B; Michielsen P; Van Gaal L
Hepatology; 2014 Jan; 59(1):121-9. PubMed ID: 24375485
[TBL] [Abstract][Full Text] [Related]
9. Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome.
de Larrañaga G; Wingeyer SP; Graffigna M; Belli S; Bendezú K; Alvarez S; Levalle O; Fainboim H
Clin Appl Thromb Hemost; 2008 Jul; 14(3):319-24. PubMed ID: 18160600
[TBL] [Abstract][Full Text] [Related]
10. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP
Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343
[TBL] [Abstract][Full Text] [Related]
11. Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease.
Jin R; Krasinskas A; Le NA; Konomi JV; Holzberg J; Romero R; Vos MB
Pediatr Obes; 2018 Jan; 13(1):23-29. PubMed ID: 27764892
[TBL] [Abstract][Full Text] [Related]
12. Sleep duration is associated with liver steatosis in children depending on body adiposity.
de Cuevillas B; Lubrecht J; Navas-Carretero S; Vreugdenhil A; Martinez JA
Eur J Pediatr; 2024 Feb; 183(2):779-789. PubMed ID: 38001309
[TBL] [Abstract][Full Text] [Related]
13. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents.
Assunção SNF; Sorte NCAB; Alves CAD; Mendes PSA; Alves CRB; Silva LR
Nutr Hosp; 2018 Jan; 35(1):78-83. PubMed ID: 29565153
[TBL] [Abstract][Full Text] [Related]
16. Serum leptin as a mediator of the influence of insulin resistance on hepatic steatosis in youths with excess adiposity.
Ramírez-Vélez R; González-Ruíz K; González-Jiménez E; Schmidt-RioValle J; Correa-Rodríguez M; García-Hermoso A; Palomino-Echeverría S; Izquierdo M
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1308-1316. PubMed ID: 33618924
[TBL] [Abstract][Full Text] [Related]
17. The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosis.
Ardigò D; Franzini L; Valtueña S; Numeroso F; Piatti PM; Monti L; Reaven GM; Zavaroni I
Atherosclerosis; 2010 Jan; 208(1):240-5. PubMed ID: 19656511
[TBL] [Abstract][Full Text] [Related]
18. Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children.
Knøsgaard L; Kazankov K; Birkebæk NH; Holland-Fischer P; Lange A; Solvig J; Hørlyck A; Kristensen K; Rittig S; Vilstrup H; Grønbæk H; Handberg A
Eur J Clin Nutr; 2016 Sep; 70(9):1073-7. PubMed ID: 27273071
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women.
Solano MP; Perry AC; Wang X; Ross R; Goldberg RB
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):82-7. PubMed ID: 12532158
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children.
Rutigliano I; Vinci R; De Filippo G; Mancini M; Stoppino L; d'Apolito M; Giardino I; Macarini L; Pettoello Mantovani M; Campanozzi A
Nutrition; 2017 Apr; 36():1-7. PubMed ID: 28336101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
